DocGo (DCGO) Q3 2026 earnings review
DocGo narrows its operating loss, but cuts its sales outlook
DocGo, a provider of ambulance transport and at-home medical visits, narrowed its operating loss by shrinking money-losing services while searching for a new chief executive. Third-quarter sales stayed at $73 million, missing the pace implied by the prior full-year plan because management pulled back on home health visits. Cutting those trips and exiting upstate New York ambulance routes lifted gross margin and halved the quarterly Ebitda loss excluding one-offs to $3 million.
| Revenue excluding 2025 migrant contracts | +18% $73.4M total (+3.7% reported from a year ago) |
|---|---|
| Gross margin, excluding one-offs | 33.3% up 2.8 percentage points from last quarter |
| Ebitda loss, excluding one-offs | -$3.2M -$6.3M last quarter |
| Full-year revenue outlook | Cut $7.5M now ~$300M (was $305–310M) |
⚖️ Verdict: 🔴 Bearish
The story got worse because management had to cut its full-year revenue outlook and shrink its home-care business to stop cash losses, while unrestricted cash fell to $19 million before an October debt draw. Outgoing chief executive Lee Bienstock revealed that one-fifth of the $300 million revenue base still loses money and faces restructuring or closure by year-end. On the positive side, ambulance volume grew and cost cuts kept the full-year profit target intact.
The question now is whether pruning unprofitable clinics and buying virtual-care provider Hicuity Health creates a self-funding business or leaves a smaller company burdened by new debt. Either the fourth quarter reaches the breakeven pace implied by the full-year outlook, or ongoing restructuring charges and interest costs keep draining cash. Fourth-quarter Ebitda excluding one-offs and the initial 2027 revenue plan will settle it.
🐂 Bull Case
Ambulance Volume and Cuts Lift Gross Margin
DocGo runs medical transport ambulances and mobile health clinics. Finance chief Norm Rosenberg highlighted a 2.8 percentage point jump in gross margin excluding one-offs over the second quarter, reaching 33.3% despite elevated fuel costs. Direct service costs fell from 69.5% of sales last quarter to 66.7%.
- Medical transportation revenue: $53.3 million, up 6.3% from a year ago on 13% higher US trip volume
- Medical transportation gross margin excluding one-offs: 34.7%, up from 32.0% last quarter
- Virtual care and lab orders volume: up 12.5% from a year ago, with the Hicuity Health virtual care acquisition on track to close in late November or early December
Exiting unprofitable markets is doing the heavy lifting. Rosenberg said that "Excluding our upstate New York market, which we plan to exit before the end of this year, medical transportation gross margins would have been 36.7%". Leaving that market will add about 1.4 percentage points to company-wide gross margin.
What to watch: fourth-quarter gross margin excluding one-offs after the upstate New York exit completes. A reading near 34.7% will confirm that dropping the region permanently fixed transport profitability.
Cost Cuts Halve the Quarterly Operating Loss
DocGo has spent the year cutting overhead and using artificial intelligence software to handle routine scheduling calls. Those savings showed up in the third quarter, as general and administrative overhead fell from 40.5% of sales in the second quarter to 39.4%, or $28.9 million.
Combined with the higher gross margin, the quarterly Ebitda loss excluding one-offs narrowed from $6.3 million in the second quarter to $3.2 million. Management kept its full-year loss outlook at $17 million to $22 million. With $19.8 million lost across the first nine months, the middle of that plan implies a $0.3 million profit in the fourth quarter, by our math.
One accounting detail tempers the improvement. The company excluded $8.5 million of one-time deal and corporate expenses from its loss figure this quarter, up from $6.2 million last quarter. Without that adjustment, the unadjusted Ebitda loss barely moved, edging from $15.2 million in the second quarter to $14.6 million.
What to watch: fourth-quarter Ebitda excluding one-offs and the size of the one-time expense add-backs. Hitting the implied $0.3 million profit without another large one-time exclusion will prove the cost cuts work on their own.
🐻 Bear Case
DocGo Shrinks Home Care to Stop Losses
DocGo partners with health insurers to visit patients at home and close care gaps, which are overdue checkups and screenings. The company added 100,000 assigned patients since last quarter to pass 1.8 million since inception, and launched a new Pennsylvania programme with a major national health plan.
Yet the actual business is shrinking because the visits lose money. In the third quarter, the mobile health provider "deliberately dialed back healthcare in the home patient outreach and clinical operations to prioritize profitability", causing home visit volume to drop 26% from a year ago. Management cut the full-year sales outlook to about $300 million from $305–310 million due to the "ongoing elimination and restructuring of unprofitable business lines".
"Our plan requires that every business line that we continue to operate contributes positive adjusted EBITDA to the portfolio," chief executive Lee Bienstock said. He disclosed that only about $240 million of the $300 million revenue base meets that standard today. That means roughly $60 million of current sales, or one-fifth of the company, loses money before corporate overhead and faces restructuring or closure by year-end.
What to watch: the initial 2027 revenue outlook next quarter. It will show how much of the $60 million unprofitable revenue base DocGo had to shut down rather than fix.
Cash Drops to $19 Million Before New Debt
Available cash has fallen every quarter this year as the business funds operating losses and lease payments. Unrestricted cash dropped by $6.1 million in the third quarter to $19.1 million, down from $25.2 million in June and $51.0 million at the end of 2025.
- Operating cash flow: -$3.6 million in the third quarter, bringing the nine-month cash burn from operations to -$17.5 million
- Free cash flow: -$4.3 million in the third quarter, by our math, after $0.7 million of equipment and software spending
- Restricted cash and investments: $21.6 million at quarter-end, tied up as collateral and unavailable for daily operations
To shore up liquidity and expand virtual care, the group is taking on debt. DocGo noted that its quarter-end cash figure "does not include the debt funding from Perceptive Advisors, which occurred on October 1 st , 2026". Closing the Hicuity Health purchase in late November or early December will also add roughly $52 million of assumed debt.
What to watch: the debt footnote in the third-quarter filing. It will disclose the exact dollar amount and interest rate of the October 1 borrowing and how much cash DocGo has advanced to Hicuity before closing.
Risks this quarter didn't answer
Five standing balance-sheet, regulatory and revenue risks received no update in the third-quarter earnings release because the full quarterly filing and conference call remarks were not included.
- Credit line covenant breach: the third-quarter filing's liquidity note will show whether lenders waived the minimum-liquidity violation that began in December 2025.
- Nasdaq listing compliance: the company has until January 25, 2027 to regain the minimum bid requirement; any reverse-split plan will appear in proxy or filing disclosures.
- Unpaid New York City migrant bills: roughly $13 million remained uncollected at the first-quarter mark; the filing's receivables footnote will show if the city paid.
- Medicare remote monitoring rules and customer concentration: cardiac and remote monitoring volume grew 8.5%, and two customers held 24% of sales last quarter; the call and filing will update exposure to 2027 Medicare rate rules and top clients.
- SteadyMD standalone revenue: management did not break out quarterly sales for its virtual care unit after reporting $8.9 million in the second quarter; the call transcript will show whether it rebounded.
👓 Other Themes
Board Launches Search to Replace Chief Executive
DocGo announced that its board of directors has begun "a comprehensive search to identify the next CEO" with recruiting firm Heidrick & Struggles because chief executive Lee Bienstock's employment contract expires on December 31, 2026. Bienstock will stay on as chief executive and a board director until a successor is named, remaining through at least March 31, 2027 to oversee the business line restructuring.
💲 Other KPIs
Uncollected customer bills fell by $3.2 million from the second quarter and are down $9.9 million since the end of 2025. Collecting old bills brought in $1.6 million of operating cash this quarter, though bad debt expense rose to $1.6 million from $1.2 million a year ago.
The diluted share count rose 1.2% from a year ago as employee stock grants continued and share buybacks remained halted for a fifth straight quarter. Closing the Hicuity Health purchase in late 2026 will add another 2.0% in new shares at closing, plus up to 3.5% in performance shares.
🔮 Guidance
Cut. Management lowered the full-year sales plan by $7.5 million from the middle of the prior range because it is shutting down or shrinking unprofitable service lines. By our math, the new target leaves $77.6 million for the fourth quarter, up 5.7% from the third quarter and up 3.5% from a year ago, excluding any contribution from Hicuity Health.
Unchanged. The full-year operating cash loss plan stays at a midpoint of -$19.5 million after management lowered it by $12 million last quarter. Because the nine-month loss is already -$19.8 million, hitting the middle of the full-year range requires a $0.3 million profit in the fourth quarter, by our math.
❓ Key Questions
How much of the $60M unprofitable revenue will shut down?
Chief executive Lee Bienstock said $60 million of the $300 million revenue base does not yet generate positive Ebitda excluding one-offs. Investors need to know how much of that revenue will be eliminated outright in 2027 versus fixed through pricing or staffing changes.
What were SteadyMD and care-gap revenues in the third quarter?
The release did not break out quarterly sales for SteadyMD virtual care ($8.9 million last quarter) or care-gap home visits ($1–2 million last quarter). Without those figures, readers cannot tell how fast the ongoing businesses grew excluding the acquired SteadyMD unit.
What are the terms of the October 1 Perceptive loan?
Unrestricted cash fell to $19.1 million before DocGo drew debt funding from Perceptive Advisors on October 1. The company has not yet disclosed in the release how much it borrowed on that date, the interest rate, or how much cash it has advanced to Hicuity Health.
Did lenders waive the minimum-liquidity covenant breach?
DocGo has been out of compliance with a minimum-liquidity covenant on its credit line since December 2025, and roughly $13 million of New York City migrant receivables remained unpaid Earlier this year. The release gives no update on either balance-sheet item.